Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.
about
Acromegaly without imaging evidence of pituitary adenoma.Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects.Management of acromegaly in Latin America: expert panel recommendationsTreatment strategies for acromegaly.Resistance to somatostatin analogs in acromegaly: an evolving concept?Dynamic tests and basal values for defining active acromegaly.Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.Testosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment.How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.Biochemical investigations in diagnosis and follow up of acromegaly.Trabecular bone score as a skeletal fragility index in acromegaly patients.Cost-effectiveness analysis of somatostatin analogues in the treatment of acromegaly in Brazil.Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status.Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend?First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.
P2860
Q30430884-585B9853-1461-449F-9A66-2ECD4658BBC3Q33739766-D4F27971-0553-424B-8847-DB0F0D7FE1B9Q33794388-A571D332-4D6C-4F15-95BF-47FBD75B86D4Q36302865-E1AA7F32-9A4A-45A7-9036-15D65FA2AFD4Q36428225-0EC4D6BB-A40A-4946-826D-09CCC9E6ECCFQ36626485-9BD0B2BF-5A64-4A60-880A-CDA221028422Q37139774-F5525B6A-791C-460A-9C45-868027778854Q37425200-7038660F-62A1-484F-9B27-4387347E83F4Q37531111-AC7C0A51-927C-4B36-B815-A0995151945BQ37930510-BC8D635C-B16B-423D-A545-6B7BD58478BBQ38373377-8AC9E35F-2779-4C72-BB55-B691F1305AE7Q39123579-A13BCD09-3DE3-4554-91E0-142FE8BFCC24Q40455150-1ED1364B-0C32-4770-B255-C95F06F152A5Q46131356-253BEBF0-AB24-42A9-B289-E1B7E1BC75BAQ46951269-AEB8B7D4-7B21-4193-BA78-AC56103952E0Q50944176-5F956AF1-8DCF-4AE0-ACFE-64E232E6F91BQ51493161-E8E9D9E3-321A-4CDB-BA6A-9049A4E35599Q51965100-F8B36558-37EF-43AE-8EBE-70CDCE80DE70Q51995940-299E40D6-D011-4C45-BA29-EB93F48D1550
P2860
Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biochemical assessment and lon ...... ety and the Pituitary Society.
@ast
Biochemical assessment and lon ...... ety and the Pituitary Society.
@en
type
label
Biochemical assessment and lon ...... ety and the Pituitary Society.
@ast
Biochemical assessment and lon ...... ety and the Pituitary Society.
@en
prefLabel
Biochemical assessment and lon ...... ety and the Pituitary Society.
@ast
Biochemical assessment and lon ...... ety and the Pituitary Society.
@en
P356
P1476
Biochemical assessment and lon ...... ety and the Pituitary Society.
@en
P2093
Growth Hormone Research Society
Pituitary Society
P304
P356
10.1210/JC.2003-031138
P407
P577
2004-07-01T00:00:00Z